MedTrace Logo

Genetic Evaluation of AAAS Gene in Early-Onset Achalasia and Alacrima Patients

NCT00856921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2009-03-06

No results posted yet for this study

Summary

The AAAS gene has been known to cause achalasia, alacrima, adrenal abnormalities and a progressive neurological syndrome. A considerable proportion of achalasia patients have been known to show alacrima (decreased secretion of tears). However, the genetic mechanism between achalasia and alacrima has not been defined yet. The investigators postulated that some proportions of early-onset achalasia could be correlated with AAAS gene; thus, the investigators aimed to investigate the relationship between the AAAS gene and early-onset achalasia.

Conditions

  • Achalasia
  • Alacrima

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-01-31
Completion
2009-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00856921 on ClinicalTrials.gov